Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II peripheral blood stem cell harvest with low-dose cyclophosphamide plus G-CSF in multiple myeloma
jRCTs031180336Phase 2Completed
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cyclophosphamide in multiple myeloma (MM). Primary endpoint: Success rate of PBSC harvest. Started Sep 2015; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on jRCTs031180336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180336.